Stock Taper 
OCTAGON CAPITAL ADVISORS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Disc Medicine, Inc. | IRON | 270K | $19.75M |
 Kymera Therapeutics, Inc. | KYMR | 310K | $35.55M |
 Trevi Therapeutics, Inc. | TRVI | 315K | $5.87M |
 Mirum Pharmaceuticals, Inc. | MIRM | 338.9K | $39.68M |
 Pharvaris N.V. | PHVS | 456.72K | $15.79M |
 Xenon Pharmaceuticals Inc. | XENE | 490K | $29.58M |
 Gyre Therapeutics, Inc. | GYRE | 954.42K | $6.29M |
 Aktis Oncology, Inc. | AKTS | 960.85K | $30.97M |
 Abivax S.A. | ABVX | 993K | $132.33M |
 Summit Therapeutics Inc. | SMMT | 1.25M | $18.21M |
 BioAge Labs Inc. | BIOA | 1.75M | $42.84M |
 Dianthus Therapeutics, Inc. | DNTH | 1.84M | $179.53M |
 ArriVent BioPharma, Inc. | AVBP | 1.97M | $68.47M |
 Ocular Therapeutix, Inc. | OCUL | 2.08M | $20.38M |
 Cogent Biosciences, Inc. | COGT | 2.35M | $90.94M |
 Alumis Inc. | ALMS | 2.83M | $79.66M |
 Definium Therapeutics, Inc. | DFTX | 2.95M | $138.77M |